A maker of cardiac and vascular medical devices and preserved human tissues, Artivion helps surgeons treat aortic disease with products like the On-X mechanical heart valve, BioGlue surgical sealant, and aortic stent grafts, while its cryopreservation service banks donated heart valves and blood vessels. It began in 1984 as CryoLife, founded by Steven Anderson and Robert McNally as the first company to specialize in freezing human heart valves. In 2022 it renamed itself Artivion, a blend of "aorta," "innovation," and "vision."
Select a row to see that insider’s individual transactions. † Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over the last year: -447.5K shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.